ARCHIVES

Phase IIb Trial of CRLX101 Fails Overall Survival Endpoint

This article is from The Cancer Letter archive.

Vol. 36 No. 3 | March 29, 2013

Download PDF Visit The Full Archive

Related Articles

Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review

January 16, 1981

NCAB Criticizes Coverage’ Of NCI Screening Statement

March 4, 1994

DCT Board To Consider RFA for Clinical R01 Grants At Next Meetings

January 21, 1994

Gottlieb questions ODAC’s independence.

August 5, 2005

NCI Cooperative Group Clinical Trials Approved

November 27, 2009

Benno Schmidt, 86, Cancer Act Advocate, Chairman Of MSKCC boards, Cancer Panel

October 29, 1999